T1 Energy Posts Best-Ever EBITDA but Stock Slumps on Legal, Trade, and Funding Overhang

Revenue tripled and EBITDA hit a record, but cash drain, Austin funding gap, and patent/tariff risks overshadowed the solar maker's strong quarter.

T1 Energy delivered what should have been a headline-grabbing quarter. Revenue tripled, adjusted EBITDA hit a record, and the solar manufacturer swung to a small profit from continuing operations — beating analyst estimates that had called for a steep loss. Yet the stock fell 7.2% on Wednesday to €4.64, a retreat that underscores the web of risks tightening around the company's growth story.

Record output, widening margins

Revenue in the first quarter of 2026 surged 232% to $177.5 million, propelled by stronger-than-expected output at the G1_Dallas facility. Gross margin widened from 10% to 17%, and adjusted EBITDA climbed to a record $9.1 million. Earnings per share from continuing operations came in at $0.01, a positive surprise for a Street that had braced for a deficit.

The improvement was partly structural. T1 shifted its sales mix away from distributor deals toward long-term contracts with fixed margins and cost-plus features, reducing third-party fees and stabilising profitability.

Cash burn clouds the picture

Beneath the operating strength, the balance sheet tells a more anxious tale. Cash and restricted cash tumbled to $123.7 million from $270.8 million at year-end. Operating cash flow was negative $72.9 million, and capital spending added another $60.7 million — a combined cash drain that explains why T1 is racing to secure fresh capital.

Adding to the strain, discontinued operations generated a $24.3 million loss, leaving a net loss attributable to common shareholders of $21.4 million for the quarter.

Funding gap for G2 Austin

The company recently upsized a convertible bond offering to $160 million (expected net proceeds of $174.7 million), with notes maturing in 2031. That covers only part of the bill for the first phase of its new factory in Austin. Management has flagged a need for roughly $225 million in additional funding, which it aims to secure in the current quarter.

Construction at the Texas site remains on track. Steel erection began in May, and the first solar cells are due off the line in the fourth quarter of 2026. Meanwhile, the G1_Dallas facility ramped its annualized production rate to 3.4 gigawatts in April, within the full-year guidance range of 3.1 GW to 4.2 GW.

Legal clouds and tariff triggers

The expansion plans sit alongside two significant external risks. First Solar has launched a patent infringement case targeting TOPCon technology, naming T1 and entities tied to G1_Dallas in a district court complaint. The suit also asks the International Trade Commission for a general exclusion order against allegedly infringing products — a move that could disrupt T1's supply chain if successful.

Trade policy adds another layer of uncertainty. The management has refrained from issuing detailed annual guidance, citing potential US tariffs under the International Emergency Economic Powers Act and an ongoing Section 232 investigation into foreign polysilicon. Yet T1 may also benefit from those same protectionist measures: long-term supply agreements with Hemlock Semiconductor and Corning lock in domestic polysilicon and wafers, positioning the company as a winner if Washington penalizes imported inputs more heavily.

Analyst split and next catalysts

Wall Street remains sharply divided. Needham & Co. and BTIG Research rate the stock a buy with a $8 target, while Alliance Global sets its target at $8.50. On the cautious side, Morgan Stanley assigns an Equal Weight rating and a $3 price objective. The stock's 116% volatility reflects that chasm — and the absence of a clear catalyst to resolve it.

For now, investors are watching two milestones: a successful funding round in the second quarter of 2026 that would remove the financing overhang, and the on-time start of cell production in Austin by year-end. T1 also reports indicative offtake demand exceeding 100% of expected capacity for 2027–2028, suggesting that if the capital and legal hurdles can be cleared, the underlying business case remains intact.